Celgene's new CEO, Mark Alles, only began his job last month, yet already he is attempting to engage with the issue of pricing when pharma is under the political spotlight in the build-up to the ...

The headline news is that Celgene chief executive Mark Alles is heading for the door, and there’s also no room for BMS’ recently-appointed chief scientific officer Thomas Lynch in the combined ...